Improvement of Live Babies Rates After ICSI, Using cpFT

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jul 5, 2021

Keywords

ClinConnect Summary

This clinical trial is investigating a new method to help improve the chances of having live babies for women under 37 years old who are undergoing a specific fertility treatment called ICSI (Intracytoplasmic Sperm Injection). The study is examining whether adding a special supplement, known as cpFT, to the environment where eggs and embryos are prepared can lead to higher birth rates after the first embryo transfer. The trial is currently looking for participants who are eligible for their first attempt at assisted reproduction and meet certain age and health criteria.

To be eligible for this trial, women need to be between 18 and 36 years old, and men must be between 18 and 58 years old. Couples must also be seeking help with fertility and planning to undergo the ICSI procedure. Participants will be closely monitored throughout the trial, and it’s important that they can follow the study requirements in France. This trial could provide valuable information on improving fertility treatments, so if you think you might qualify, it’s a good idea to discuss it with your doctor.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Couples eligible for a first attempt at Assisted Reproduction (AMP).
• • Couples asking for Assisted Reproductive Technology, and requiring an ICS procedure.
• • Women aged 18 to 36 inclusive.
• • Men aged 18 to 58 inclusive
• • Use of CSCM-C culture medium from Biocare / Irvine, exclusively.
• • People affiliated to a Social Security scheme
• Exclusion Criteria:
• • Lack of consent
• • Early menopause.
• • Couples under IVF or Intra Uterine Insemination treatment.
• • People unable to follow protocol visits in France.
• • Couple with a contraindication to treatment with ART.
• • Women with a contraindication to treatment with ART or an associated pathology such as: hypertension, risk of eclampsia, family genetic problems, diabetes, uterine partitions, synechiae adhesions, adenomyosis or any other contraindication judged as such by the investigator.
• • ART with donation of gametes or embryos.
• • Participant under guardianship or guardianship

Trial Officials